Osimertinib Vs. Comparative Egfr Tki As First-Line Therapy In Egfrm Advanced Nsclc (Flaura): Final Overall Survival AnalysisS. Bohnet, Meyer C. Zu Bueschenfelde,H. Bischoff,N. Reinmuth,A. Rueckert,R. Hodge,Y. Rukazenkov,S. S. RamalingamPNEUMOLOGIE(2020)引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要